ESMO Immuno-Oncology Congress 2021 Dec 8 - Dec 11 2021 58P - Validation of the Achilles VELOSTM Process 2 manufacturing platform for the treatment of solid cancer: GMP scale runs generate a significant dose boost of highly potent clonal neoantigen reactive T cells Supporting Materials ESMOIO 2021 Poster 963.7 KB Back to Events +
